Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3).-论文-万方医学网

第一作者： Abir Salwa,Ali

第一单位： Department of Medical Sciences, Section of Endocrine Oncology, Uppsala University, Uppsala, Sweden. abir.ali@medsci.uu.se.

作者： Abir Salwa,Ali ^[1] ; Malin,Grönberg ^[2] ; Seppo W,Langer ^[3] ; Morten,Ladekarl ^[4] ; Geir Olav,Hjortland ^[5] ; Lene Weber,Vestermark ^[6] ; Pia,Österlund ^[7] ; Staffan,Welin ^[8] ; Henning,Grønbæk ^[9] ; Ulrich,Knigge ^[2] ; Halfdan,Sorbye ^[10] ; Eva Tiensuu,Janson ^[3]

作者单位： Department of Medical Sciences, Section of Endocrine Oncology, Uppsala University, Uppsala, Sweden. abir.ali@medsci.uu.se. ^[1] Department of Medical Sciences, Section of Endocrine Oncology, Uppsala University, Uppsala, Sweden. ^[2] Departments of Surgery C and Endocrinology PE, Rigshospitalet, Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark. ^[3] Department of Oncology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. ^[4] Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. ^[5] Department of Oncology, Oslo University Hospital, Oslo, Norway. ^[6] Department of Oncology, Odense University Hospital, Odense, Denmark. ^[7] Department of Oncology, Tampere University Hospital and Tampere University, Tampere, Finland. ^[8] Department of Oncology, Helsinki University Hospital and Helsinki University, Helsinki, Finland. ^[9] Departments of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark. ^[10] Department of Oncology, Haukeland University Hospital, Bergen, Norway. ^[11]

主题词投药, 口服(Administration, Oral);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤药, 植物(Antineoplastic Agents, Phytogenic);无病生存(Disease-Free Survival);依托泊甙(Etoposide);女(雌)性(Female);人类(Humans);输注, 静脉内(Infusions, Intravenous);肠肿瘤(Intestinal Neoplasms);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);中年人(Middle Aged);神经内分泌瘤(Neuroendocrine Tumors);胰腺肿瘤(Pancreatic Neoplasms);比例危险度模型(Proportional Hazards Models);回顾性研究(Retrospective Studies);胃肿瘤(Stomach Neoplasms);治疗结果(Treatment Outcome)

DOI 10.1007/s12032-018-1103-x

PMID 29511910

发布时间 2018-11-14

检索历史清除

Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3).

Medical oncology (Northwood, London, England)

相似文献

Medical oncology (Northwood, London, England)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3).

Medical oncology (Northwood, London, England)

相似文献

Medical oncology (Northwood, London, England)

相关期刊

检索历史清除